The WACC of Briacell Therapeutics Corp (BCT.TO) is 8.0%.
| Range | Selected | |
| Cost of equity | 10.10% - 14.60% | 12.35% |
| Tax rate | 25.90% - 26.50% | 26.20% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 6.9% - 9.2% | 8.0% |
| Category | Low | High |
| Long-term bond rate | 3.2% | 3.7% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 1.37 | 1.72 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 10.10% | 14.60% |
| Tax rate | 25.90% | 26.50% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 6.9% | 9.2% |
| Selected WACC | 8.0% | |